StonvexLoading…
StonvexStonvexStonvexCore line items from BLNE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 | Q1 2024 2024-03-31 | Annual 2023 2023-12-31 |
|---|---|---|---|---|
Revenue | $1.98M | $5.36M | $2.41M | $10.50M |
Operating Income | $-1.15M | $-714.00K | $-461.00K | $-2.42M |
Net Income | $-4.14M | $-2.78M | $-1.29M | $-7.54M |
EPS (Diluted) | $-22.84 | $-16.55 | $-0.78 | $-70.42 |
Total Assets | $16.22M | $16.59M | $17.02M | $17.48M |
Total Liabilities | $18.68M | $18.52M | $17.50M | $16.63M |
Cash & Equivalents | $310.00K | $420.00K | $147.00K | $306.00K |
Free Cash Flow OCF − CapEx | Not available | $-956.20K | Not available | $-1.88M |
Shares Outstanding | 3.14M | 1.76M | 1.71M | 170.60K |